|
TMEM85 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.331690E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.660900E-03 |
| Normal-vs-Stage2 |
1.597660E-02 |
| Normal-vs-Stage3 |
5.026600E-01 |
| Normal-vs-Stage4 |
1.124980E-01 |
| Stage1-vs-Stage2 |
5.091200E-01 |
| Stage1-vs-Stage3 |
4.763600E-03 |
| Stage1-vs-Stage4 |
2.520800E-01 |
| Stage2-vs-Stage3 |
3.452200E-02 |
| Stage2-vs-Stage4 |
2.045600E-01 |
| Stage3-vs-Stage4 |
2.401000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.240170E-02 |
| Normal-vs-AfricanAmerican |
1.034170E-01 |
| Normal-vs-Asian |
4.066200E-01 |
| Caucasian-vs-AfricanAmerican |
8.285600E-01 |
| Caucasian-vs-Asian |
6.758200E-02 |
| AfricanAmerican-vs-Asian |
7.026000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.564400E-02 |
| Normal-vs-Female |
5.404000E-03 |
| Male-vs-Female |
1.002640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.715820E-01 |
| Normal-vs-Age(41-60Yrs) |
3.936300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.966300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.158100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.808800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.366000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.004200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.573600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.521600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.433400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.409600E-04 |
| Normal-vs-Grade 2 |
3.998800E-04 |
| Normal-vs-Grade 3 |
2.169200E-01 |
| Normal-vs-Grade 4 |
9.603000E-01 |
| Grade 1-vs-Grade 2 |
2.156400E-01 |
| Grade 1-vs-Grade 3 |
1.502640E-03 |
| Grade 1-vs-Grade 4 |
1.631310E-04 |
| Grade 2-vs-Grade 3 |
3.016200E-04 |
| Grade 2-vs-Grade 4 |
1.586740E-04 |
| Grade 3-vs-Grade 4 |
1.324610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.364100E-04 |
| Normal-vs-ccB subtype |
8.902000E-01 |
| ccA subtype-vs-ccB subtype |
1.5239999995309E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.886300E-02 |
| Normal-vs-N1 |
4.269600E-01 |
| N0-vs-N1 |
3.941700E-02 |
|
|
